allevo + vincristine + lomustine + etoposide + dexamethasone

This is a combination chemotherapy regimen consisting of five agents: - Allevo (identity unclear, possibly a brand or investigational name not found in standard references) - Vincristine, a vinca alkaloid that inhibits microtubule formation and arrests cell division - Lomustine, an alkylating nitrosourea compound that cross-links DNA and RNA - Etoposide, a topoisomerase II inhibitor causing DNA strand breaks - Dexamethasone, a synthetic glucocorticoid with anti-inflammatory and immunosuppressive effects Such multi-agent regimens are used in oncology to target cancer cells through different mechanisms. Vincristine is commonly used for leukemias and lymphomas[3][6][10], lomustine and etoposide are often included in protocols for brain tumors or small cell lung cancer[7], while dexamethasone serves both as an anti-cancer agent (especially in hematologic malignancies) and to reduce inflammation or chemotherapy-induced nausea[8]. The specific use of this exact five-drug combination under the name "Allevo" could not be confirmed from available sources.